Institut de Cancerologie de l'Ouest Paul Papin
Also known as: Centre Regional Rene Gauducheau | Centre René Gauducheau | Centre René Gauducheau / Institut de Cancérologie de l'Ouest | Centre Rene Gauducheau NANTES France | Centre R Gauducheau | ICO Paul Papin | ICO - Paul Papin - Angers | ICO site SAINT HERBLAIN | Institut Cancerologie de l'Ouest | Institut de Cancérologie de l'Ouest | Institut de Cancerologie de l'Ouest | INSTITUT DE CANCEROLOGIE DE L'OUEST | Institut de cancérologie de l'Ouest | Institut de Cancérologie de l'Ouest | Institut de Cancérologie de l'Ouest - Saint Herblain | Institut de Cancerologie de l'Ousest - ICO | Institute Cancer Of L'ouest
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2011Last known activity
Feb 28, 2026
Timeline
2010s
- Jun 1, 2011
Institut de Cancerologie de l'Ouest Paul Papin— Founded
Drugs by trial phase (58 distinct, 47 trials)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (30 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Astrocytoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Central Nervous System Neoplasms
- Colorectal Neoplasms
- Disease Progression
- Esophageal Neoplasms
- Gastrointestinal Neoplasms
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Hypoxia
- Leukemia
- Leukemia, Lymphoid
- Lung Neoplasms
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Nervous System Neoplasms
- Neuralgia
- Neurotoxicity Syndromes
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07260162Lead sponsorPhase 1Feb 28, 2026
- NCT06967987Lead sponsorPhase 2Dec 30, 2025
- NCT06967987OfficialPhase 2Dec 30, 2025
- NCT07007325Lead sponsorEarly Phase 1Sep 15, 2025
- NCT06471465OfficialPhase 3Dec 31, 2024
- NCT06471465Lead sponsorPhase 3Dec 31, 2024
- NCT05840562Lead sponsorPhase 3Sep 30, 2023
- NCT05840562Study directorPhase 3Sep 30, 2023
- NCT04897763Study chairEarly Phase 1Oct 1, 2021
- NCT04897763Lead sponsorEarly Phase 1Oct 1, 2021
- NCT04899492Lead sponsorN/ASep 29, 2021
- NCT04758780Study chairPhase 2Sep 21, 2021
- NCT04758780Lead sponsorPhase 2Sep 21, 2021
- NCT04666961Overall official - principal investigatorPhase 2Feb 3, 2021
- NCT04666961Lead sponsorPhase 2Feb 3, 2021
Details
- Founded
- Angers, FR Jun 1, 2011
- Last known activity
- Feb 28, 2026